Kura Oncology (KURA) Tops Q4 EPS by 8c

Kura Oncology (NASDAQ: KURA) reported Q4 EPS of ($0.49), $0.08 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Broadcom shares fall 3% after revenue forecast misses estimates
• Snowflake soars 20% on earnings beat and raised guidance